Latest news with #M&M
Business Wire
a day ago
- Science
- Business Wire
Thermo Fisher Scientific Increases Accessibility to Research With the Launches of Scios 3 and Talos 12 Electron Microscopes at M&M 2025 Conference
BUSINESS WIRE)--As the world leader in serving science, Thermo Fisher Scientific is proud to announce the launch of two new electron microscopes that will be unveiled at Microscopy & Microanalysis (M&M) in Salt Lake City, Utah, July 27-31, each significantly contributing to the democratization of research in the sciences. Scios 3 FIB-SEM offers high-powered versatility The Thermo Scientific™ Scios™ 3 is a focused ion beam (FIB) scanning electron microscope (SEM) with automation to dramatically improve site-specific quality control. The Scios 3 FIB-SEM offers increased productivity for both industry and academia with enhanced lamella preparation, due to advances in FIB column performance. Ease-of-use upgrades will benefit microscopists of all experience levels. 'Researchers across the globe seek new and better materials for various applications – from clean energy and aerospace to productivity of digital devices,' said David Wall, vice president and general manager of materials science for Thermo Fisher. 'The current pace of the development of new materials and their increasing complexity poses significant challenges, and Scios 3 addresses those challenges head-on with world-class advancements designed to serve both academia and industry.' With advanced automation and high-throughput, Scios 3 improves ease of use, reliability and productivity. To learn more, stop by booth #1734 at M&M for a live demonstration or visit Talos 12 adapts to researchers across disciplines and experience levels Thermo Fisher has evolved the popular Talos transmission electron microscope (TEM) design, culminating in the Thermo Scientific Talos™ 12 TEM, making leading-edge sample analysis more accessible than ever for biological research, pathology and drug development. 'We're pleased to introduce Talos 12 at M&M this year to bring transmission electron microscopy to more researchers,' said Trisha Rice, vice president and general manager of life sciences at Thermo Fisher. 'A wide array of laboratories can now benefit from this adaptable 120kV instrument. Not only does the reduced footprint and next-generation enclosure fit into more lab spaces, but the streamlined workflows – from routine imaging of cells and tissues to AI-assisted sample characterization to cryo-EM – enable the user-friendly Talos 12 to support remote operation for collaboration regardless of location.' TEM systems often require highly skilled specialists, but Talos 12 lowers those requirements with new enhancements to improve ease of use while maintaining high quality imaging with high reproducibility. To learn more, stop by booth #1734 at M&M for a live demonstration or visit Stop by booth #1734 to see Scios, Talos and more Thermo Fisher will have a significant presence at the Salt Palace Convention Center. In addition to live demonstrations of Scios 3 and Talos 12, several other industry-leading solutions will be on full display. Stop by booth #1734 to engage with Thermo Fisher subject-matter experts as they discuss the latest advancements in microscopy innovation and analytical research technology. Additionally, Thermo Fisher has hosted a 'Women in Microscopy' breakfast at M&M for more than two decades and will continue that tradition at the Hyatt Regency on the morning of July 30. Dr. Amelia Dempere, Director of the Nanoscale Research Facility (NRF) at the University of Florida, will talk about her career journey and the ever-increasing importance of women in research. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit
New York Times
a day ago
- Science
- New York Times
How an M&M Sparked the Search for the Next Perfect Peanut
The Peanut M&M was in trouble. It was the early 2000s, and complaints about rancid nuts were piling up at Mars headquarters in McLean, Va., so fast they had outpaced the combined consumer complaints about Snickers, Twix and even the company's extensive dog food line. So the world's largest confectionary company went hunting for a new peanut to solve the problem. Plant breeders had discovered a genetic mutation that produced peanuts with plenty of monounsaturated fat, like the kind found in olive oil. That meant they were healthier and less likely to turn rancid. It was a start, but Mars — a company that refers to the peanut as its 'hero ingredient' — needed more. They wanted a peanut that was perfectly symmetrical with sweet, roasted notes. It had to stay crunchy inside a ball of chocolate, and have a skin that kept it from splitting and was a touch bitter to balance the sweetness. It had to grow so well in the Southern peanut belt that farmers would be willing to switch out their tried and true seeds for something new. Peanut researchers at the University of Georgia got to work and created the Georgia-09B, a runner peanut that did everything the candy maker wanted. By 2017, Mars was using nothing but high-oleic peanuts in its M&Ms, most of them Georgia-09Bs. 'Since then, customer complaints have reduced by over 90 percent,' said Peggy Tsatsos, who leads research for the Mars nut science team. Now, with $3.5 million from Mars, scientists at the university's Wild Peanut Lab are trying to help Mars out of another jam. Want all of The Times? Subscribe.
&w=3840&q=100)
Business Standard
2 days ago
- Automotive
- Business Standard
M&M shares hit new high, soar 40% from April low; more upside ahead?
Driven by a strong order backlog and new launches, Motilal Oswal Financial Services expects M&M to continue outperforming industry growth in FY26 Deepak Korgaonkar Mumbai Listen to This Article Mahindra & Mahindra (M&M) share price today Mahindra & Mahindra (M&M) shares hit an all-time high of ₹3,302.90 today, gaining 1.3 per cent on the BSE in Wednesday's intraday trade, on a healthy business outlook. The stock price of the automobile company surpassed its previous high of ₹3,276.30, which it had touched on February 10, 2025. It has bounced back 40 per cent from its 52-week low level of ₹2,360.45, touched on April 7, 2025. In the past one year, M&M shares have outperformed the market and the auto index by surging 17 per cent. In comparison, the BSE Sensex
Mint
3 days ago
- Business
- Mint
Stock Picks: Sagar Doshi suggests Balkrishna Industries, Hindalco, M&M shares to buy today
Stock market today: India's stock benchmarks opened higher on Wednesday, following the upward trend in their Asian counterparts after the US disclosed a trade agreement with Japan, raising hopes for additional deals. Nevertheless, the ongoing uncertainty regarding the interim trade agreement between India and the US, ahead of President Donald Trump's August 1 deadline, restrained the advances in the Indian market. The Nifty 50 increased by 0.22% to reach 25,122.75 points, while the Sensex climbed 0.30% to 82,430.50 as of 9:15 IST. Japanese stocks spearheaded the rally in Asian markets on Wednesday following the announcement of the trade agreement. MSCI's widest index for Asia-Pacific stocks, excluding Japan, also rose by 0.7%. Nifty 50 has entered a consolidation zone once again, though broader trend indicates upside from current levels, but absence of tailwinds are keeping the index in range. We continue with our view on a broad consolidation between 24,800 and 25,320 for the balance of this week, given the chart structure and positioning based on derivative data. On the options front as well, given tomorrow weekly expiry, highest call and put writing is seen at 25,200 and 24,800 respectively, furthering our stance on rangebound play for this week. After reclaiming its resistance of 56,750 in Monday's session, the index is now eyeing for a break above 57,100 to allow momentum on the long side on Bank Nifty 50. Outperformance against Nifty 50 which has been the powering the underlying current on this index, a close above 57,100 is now essential for the outperformance to continue. On the flip side, closing below 56,200 could allow downward pressure on the index. On stocks to buy on Wednesday, Sagar Doshi of Nuvama recommended three stocks - Balkrishna Industries Ltd, Hindalco Industries Ltd, and Mahindra & Mahindra Ltd (M&M). Balkrishna Industries share price has given a cup and handle breakout on daily chart at the start of this week. This pattern has been in place from the start of this calendar year marking an end of its 6 month consolidation. Given the set up this suggests for a 10-12% upside from current levels. Hindalco share price has given a 9 month trendline breakout same time last month, but the stock had been missing follow through, a retest and back to the breakout price has made way for a follow through to play out. Stock has also sustained above its 200 DMA for four consecutive weeks now, enabling for further upside on charts. Breaking out from its 5 month consolidation, M&M share price had shown early signs of reclaiming its all-time high given the cup and handle breakout last month. A retest of the same neckline has also been complete furthering the stance for another 10-12% upside from CMP. M&M has also given highest ever closing yesterday on daily charts. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Mint
3 days ago
- Automotive
- Mint
Tesla and Mahindra: A drive in parallel universes
Company Outsider is a weekly newsletter by Sundeep Khanna. Subscribe to Mint's newsletters to get them directly in your email inbox. Mahindra & Mahindra (M&M) group chairman Anand Mahindra welcomed Tesla's India entry with a friendly 'Competition drives innovation, and there's plenty of road ahead' post on X. His confidence is not misplaced. In the most recent quarter, M&M surpassed Hyundai to become India's second-largest automaker by volume. But his aplomb obscures a more fundamental truth: Tesla and M&M operate in two entirely different markets - not segments. Indeed, in automotives, they belong to two parallel universes. Their vehicles, customers, pricing, and value propositions are so distinct that the two brands are unlikely to ever compete directly in India. It's a common fallacy to treat the Indian automobile market as a single, homogenous entity. In reality, it is bifurcated into two sharply distinct sectors: a mass-market, value-conscious segment that forms more than 99% of volumes, and a narrow, high-end luxury segment that is economically and behaviorally different. While Tesla, M&M, and Indian EV market leader Tata Motors, are loosely grouped under the electric vehicle (EV) banner, that's where the similarities end. Tesla is entering at the very top of the pyramid, with its first offering in India priced at over ₹ 60 lakh (more than twice what the most expensive EV from Tata Motors costs). That places it squarely in the ultra-premium category alongside German brands like Mercedes-Benz, Audi, and BMW. By contrast, EVs from M&M and Tata Motors are tailored for cost-conscious customers and are promoted for their cost-saving benefits like lower running costs compared to petrol and diesel vehicles. No one will buy a Tesla in India to save on fuel bills. The US company's brand promise revolves around performance, tech-savvy design, and global cachet. M&M's promise, like that of Tata Motors, is rooted in practicality and affordability. The distinction is critical. In 2023, the entire luxury car segment in India accounted for just over 51,000 vehicles. That's a number Tesla sells in the US every month. It sold 657,000 units in China last year, despite growing competition from domestic giant BYD. By contrast, Tata Motors sold over 61,000 EVs in India last year. Clearly, Tesla cannot win the volume game in India simply because at its price points, volumes simply don't exist. Tesla's India ambitions are often rationalized in terms of geopolitical strategy. The country offers a hedge against an increasingly protectionist China, and the tag of being one of the few remaining 'unconquered' markets of scale. But while India may be the world's third-largest car market, it is not one for luxury EVs. There is also little reason to believe that the Indian government will bend over backward for Tesla. Unlike in the past, when market access was often traded for manufacturing commitments, today's policy approach is more guarded. Import duties are unlikely to be slashed, and Tesla will have to adhere to conditions like local sourcing and production. The government's stated target of 30% EV penetration by 2030 will be achieved primarily through sub- ₹ 15 lakh vehicles, which is the domain of Indian carmakers, and increasingly of Chinese companies like BYD. Tesla has no product in this space and, more importantly, no roadmap to get there. Despite promises of a $25,000 EV, Tesla has repeatedly deprioritized its commitment to produce an affordable EV. Five years ago, Elon Musk announced it would arrive in three years, only to go back on his promise in 2022. Today, Tesla's focus has shifted to the robotaxi platform. The message is clear: affordability is not the current focus. India's car market is not just small at the top, it is fiercely cost-conscious at every level. According to a recent Crisil Ratings report, used car sales in the country are expected to grow at twice the pace of new car sales in FY26. Significantly, the average age of used cars has declined to just 3.5 years, a strong indicator that consumers are looking for newer vehicles at lower price points. Maruti Suzuki chairman R.C. Bhargava recently noted that only the top 12% of Indian households can realistically afford a car. The other 88% struggle to afford even the entry-level models. This reality further underlines the irrelevance of Tesla's pricing strategy in the Indian context. Tesla's India foray is unlikely to ruffle feathers at M&M or disrupt the broader market. If anything, it will reinforce the market's duality of a high-end niche for brands like Tesla, and a mass-market battlefield where the real action takes place. Anand Mahindra and his team can rest easy: Tesla's India drive is on a completely different highway.a
